Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Assessment of Safety and Efficacy of Levemir (Insulin Detemir) Treatment for Insulin Naive Patients With Type 2 Diabetes Mellitus.

Trial Profile

Assessment of Safety and Efficacy of Levemir (Insulin Detemir) Treatment for Insulin Naive Patients With Type 2 Diabetes Mellitus.

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Oct 2014

At a glance

  • Drugs Insulin detemir (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Acronyms IDEALS
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 26 Jul 2011 Actual end date changed from Jul 2009 to Sep 2009 as reported by ClinicalTrials.gov
    • 26 Jul 2011 Actual initiation date changed from Jun 2008 to Jan 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top